Literature DB >> 35067804

Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.

Philipp Hendrix1,2, Christopher J Whiting3, Christoph J Griessenauer1,4, Christian Bohan1, Clemens M Schirmer1,4, Oded Goren5.   

Abstract

Venous sinus stenting (VSS) for idiopathic intracranial hypertension (IIH) has been demonstrated to achieve significant symptom improvement while harboring a low periinterventional morbidity profile. Comprehensive neuro-ophthalmological monitoring represents a cornerstone of disease monitoring. The value of optical coherence tomography (OCT) requires further exploration. Patients with IIH and papilledema who underwent VSS between 04/2018 and 02/2021 were retrospectively reviewed. Clinical and radiological were analyzed. Neuro-ophthalmological data included visual acuity, visual fields, fundoscopy categorized via Frisén scale, and OCT obtained retinal nerve fiber layer (RNFL) thickness were analyzed. Of 39 IIH patients who underwent cerebral angiography with transverse-sigmoid sinus pressure evaluation, 18 patients with IIH and papilledema underwent 21 transverse-sigmoid sinus stenting (TSST) procedures. After TSST, manometry showed a significant reduction of maximum transverse sinus pressures and trans-stenotic gradient pressures (p = 0.005 and p < 0.001, respectively). Chronic headaches, visual disturbance resolved and pulsatile tinnitus improved significantly. Visual fields remained similar, while papilledema Frisén scales and visual acuity significantly improved. The OCT calculated RNFL thickness significantly decreased in all patients. Stratification according to a minimal-low degree (Frisén 1-2) and moderate-marked degree (Frisén 3-4) papilledema demonstrated a significant reduction of RNFL thickness in both groups. Venous sinus stenting provides favorable clinical and neuro-ophthalmological outcomes. This study demonstrates that neuro-ophthalmologic testing augmented with OCT evaluation provides objective data that can be used as a biomarker for treatment success for managing patients with different extents of papilledema and may inform patient management.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Idiopathic intracranial hypertension; Optical coherence tomography; Venous sinus stenting

Year:  2022        PMID: 35067804     DOI: 10.1007/s10143-022-01742-2

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  21 in total

Review 1.  Diagnostic criteria for idiopathic intracranial hypertension.

Authors:  Deborah I Friedman; Daniel M Jacobson
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

2.  Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study.

Authors:  Kenneth C Liu; Robert M Starke; Christopher R Durst; Tony R Wang; Dale Ding; R Webster Crowley; Steven A Newman
Journal:  J Neurosurg       Date:  2016-12-23       Impact factor: 5.115

3.  Pharmacy-Mediated Antiplatelet Management Algorithm Surrounding Neurointerventional Stenting and Flow Diversion Procedures.

Authors:  Christoph J Griessenauer; Shamsher S Dalal; Stacey A Grassi; Tarun Bhalla; Clemens M Schirmer
Journal:  World Neurosurg       Date:  2017-10       Impact factor: 2.104

4.  Quality of life, need for retreatment, and the re-equilibration phenomenon after venous sinus stenting for idiopathic intracranial hypertension.

Authors:  Rebecca M Garner; Jennifer Bernhardt Aldridge; Stacey Q Wolfe; Kyle M Fargen
Journal:  J Neurointerv Surg       Date:  2020-07-01       Impact factor: 5.836

Review 5.  Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting.

Authors:  Kyle M Fargen; Kenneth Liu; Rebecca M Garner; Garret P Greeneway; Stacey Q Wolfe; R Webster Crowley
Journal:  J Neurointerv Surg       Date:  2018-07-20       Impact factor: 5.836

6.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

7.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

8.  Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss.

Authors:  J J Corbett; P J Savino; H S Thompson; T Kansu; N J Schatz; L S Orr; D Hopson
Journal:  Arch Neurol       Date:  1982-08

Review 9.  Understanding the complex pathophysiology of idiopathic intracranial hypertension and the evolving role of venous sinus stenting: a comprehensive review of the literature.

Authors:  Nisha Giridharan; Smruti K Patel; Amanda Ojugbeli; Aria Nouri; Peyman Shirani; Aaron W Grossman; Joseph Cheng; Mario Zuccarello; Charles J Prestigiacomo
Journal:  Neurosurg Focus       Date:  2018-07       Impact factor: 4.047

Review 10.  Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting.

Authors:  J N P Higgins; C Cousins; B K Owler; N Sarkies; J D Pickard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.